U.S. Adverse Event Reporting Regulations for Drugs, Dietary Supplements and Cosmetics

Conferences

Health and Medicine

Added by Referral on 2019-04-17

Conference Dates:

Start Date: 2019-06-04
Last Date

Last Day: 2019-06-04

Deadline for abstracts/proposals: 2019-06-02

Conference Contact Info:

Contact Person: Ashutos Swain
Email

Email: [email protected]
Address

Address: 2479 E. Bayshore Road Suite 260, Palo Alto, CA, 94303, United States
Phone

Tel: 8887172436
Phone

Fax: [email protected]

Get Direction and MAP

Visit Website

Share |

U.S. Adverse Event Reporting Regulations for Drugs, Dietary Supplements and Cosmetics

Enlarge Image

Conference Description:

In order to market dietary supplements and OTC drugs in the U.S., reporting serious adverse events is required. It’s essential to understand these important FDA requirements to assure regulatory compliance and avoid an FDA warning letter or 483 audit issues.

Back